Trial
NCT03015792
Ibrutinib, Lenalidomide, and Dexamethasone in Treating Patients With Multiple Myeloma Ineligible for Transplant
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Mayo Clinic
Collaborators
—
Condition
Recurrent Plasma Cell Myeloma
Intervention
Dexamethasone
Why stopped
Drug company decided to not fund the phase 2 portion
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-08-17